Prospective Study on Artelon® Tissue Reinforcement in Repair of Chronic Ruptures and Re-ruptures of the Achilles Tendon

June 29, 2015 updated by: Orthopedic Foot and Ankle Center, Ohio
The aim of this study is to evaluate the surgical and clinical outcome of Artelon® Tissue Reinforcement in repair of chronic ruptures or re-ruptures of the Achilles tendon, with regard to lower leg and foot function, pain and quality of life.

Study Overview

Status

Terminated

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

4

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Westerville, Ohio, United States, 43082
        • Orthopedic Foot and Ankle Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The patient has a clinically confirmed isolated chronic rupture or rerupture of the Achilles tendon.
  2. The patient has been informed about the study and signed the patient consent form.
  3. The patient reads, understands and is able to complete the study questionnaires in English.

Exclusion Criteria:

  1. The patient has an ongoing infection of the soft tissues of the ankle.
  2. The patient has evidence of severe ankle arthritis.
  3. The patient has a multi-system or multi-limb trauma.
  4. The patient has a major medical condition that would affect quality of life and influence the results of the study.
  5. The patient is pregnant
  6. The patient is not expected to complete the study according to the investigation plan.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Artelon
This is an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon Tissue Reinforcement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability
Time Frame: 3 months
3 months
The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability
Time Frame: 6 months
6 months
The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot
Time Frame: 3 months
3 months
General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire
Time Frame: 3 months
3 months
Range of Motion, Strength and Calf Circumference
Time Frame: 3 months
3 months
Subjective Evaluation of Treatment
Time Frame: 3 months
3 months
Return to Work and Previous Physical Activities
Time Frame: 3 months
3 months
Clinical Evaluation Including Adverse Events
Time Frame: 3 months
3 months
The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot
Time Frame: 6 months
6 months
General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire
Time Frame: 6 months
6 months
Range of Motion, Strength and Calf Circumference
Time Frame: 6 months
6 months
Subjective Evaluation of Treatment
Time Frame: 6 months
6 months
Return to Work and Previous Physical Activities
Time Frame: 6 months
6 months
Clinical Evaluation Including Adverse Events
Time Frame: 6 months
6 months
The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot
Time Frame: 12 months
12 months
General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire
Time Frame: 12 months
12 months
Range of Motion, Strength and Calf Circumference
Time Frame: 12 months
12 months
Subjective Evaluation of Treatment
Time Frame: 12 months
12 months
Return to Work and Previous Physical Activities
Time Frame: 12 months
12 months
Clinical Evaluation Including Adverse Events
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Terrence M Philbin, DO, Orthopedic Foot and Ankle Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2010

Primary Completion (ACTUAL)

February 1, 2014

Study Completion (ACTUAL)

February 1, 2014

Study Registration Dates

First Submitted

September 16, 2010

First Submitted That Met QC Criteria

November 8, 2010

First Posted (ESTIMATE)

November 9, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

July 22, 2015

Last Update Submitted That Met QC Criteria

June 29, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KP027ext

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendon Rupture

Clinical Trials on Artelon

3
Subscribe